The Hospital Universitario del Henares is a hospital in Coslada, Spain, part of the hospital network of the Servicio Madrileño de Salud. The non-medical services are managed by Sacyr.

There are 194 beds in Hospital Universitario del Henares.

During the past decade, Hospital Universitario del Henares conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario del Henares" #1 sponsor was "Anavex Life Sciences Corp." with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "University of Birmingham" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario del Henares" #1 collaborator was "Anavex Germany GmbH" with 2 trials as a collaborator, "Anavex Australia Pty Ltd." with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator, "Biocompatibles UK Ltd" with 1 trials as a collaborator and "European Regional Development Fund" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario del Henares" are "COVID-19" (2 trials), "Coronavirus" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Lung Cancer" (2 trials) and "Parkinson Disease" (2 trials). Many other conditions were trialed in "Hospital Universitario del Henares" in a lesser frequency.

Most popular intervention types in "Hospital Universitario del Henares" are "Drug" (9 trials), "Other" (6 trials), "Device" (2 trials), "Diagnostic Test" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "ANAVEX2-73" (1 trials), "Archival Tumor Tissue Sample" (1 trials) and "Bupivacaine low dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario del Henares" are 20 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario del Henares". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Hospital Universitario del Henares, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario del Henares, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".